January 5, 2016
CHICAGO, IL – January 5, 2016 — SAMDI Tech is expanding its executive leadership team as it announces Michael D. Scholle as its Vice President of Operations and Technology. Scholle had been SAMDI Tech’s Director of Operation and Technology since 2011. He brings over 15 years of experience in the biotechnology and CRO space focused on all aspects of drug discovery research.
“I am excited to continue growing SAMDI Tech’s capabilities and client base while advancing drug discovery for our diverse list of client targets,” said Scholle.
“Michael Scholle’s role in SAMDI Tech as been instrumental and his leadership in the company, through this appointment, will continue to bring to SAMDI Tech to the forefront of drug discovery research.” said Dr. Emilio Córdova, CEO of SAMDI Tech.
SAMDI is a unique label-free assay platform for measurement of complex biochemical activity.
Scholle holds a Bachelor of Science and Master of Science from Northern Illinois University and Master of Business Administration from Roosevelt University-Chicago.
About SAMDI Tech, Inc
SAMDI Tech, Inc, headquartered in Chicago, IL is a contract research organization supporting discovery research. SAMDI’s pioneering technology combines surface chemistry and MALDI mass spectrometry in both 384 and 1536 format for rapid assay development, high-throughput screening, and peptide substrate discovery and supports both biotech and large pharmaceutical companies. Learn more about SAMDI Tech at www.samditech.com.
For More Information:
SAMDI Tech, Inc.
Chief Executive Officer
Phone: +1 312 235 3575